Logo

A-Courtin'

Jul 29, 2010

Sanofi-Aventis wants to make its interest in Genzyme official, reports the Wall Street Journal's Health Blog. Last week, the Journal reported that "the two sides have begun sounding out each other's interest in a deal before entering into formal talks and a completed transaction is far away." This week, the New York Times says that "Sanofi-Aventis is likely to make an unsolicited offer of up to $70 a share for Genzyme," which would then total $18.6 billion and "could become one of the year's biggest deals."

Breaking News
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.